327 related articles for article (PubMed ID: 37029339)
1. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
[TBL] [Abstract][Full Text] [Related]
2. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
Luo L; Shan R; Cui L; Wu Z; Qian J; Tu S; Zhang W; Xiong Y; Lin W; Tang H; Zhang Y; Zhu J; Huang Z; Li Z; Mao S; Li H; Hu Z; Peng P; He K; Li Y; Liu L; Shen W; He Y
United European Gastroenterol J; 2023 Mar; 11(2):228-241. PubMed ID: 36905230
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study.
Wang L; Lin N; Lin K; Xiao C; Wang R; Chen J; Zhou W; Liu J
J Gastrointest Surg; 2021 May; 25(5):1172-1183. PubMed ID: 32440804
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
[No Abstract] [Full Text] [Related]
8. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
9. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
Wang Y; Ge H; Hu M; Pan C; Ye M; Yadav DK; Zheng R; Wu J; Sun K; Wang M; Tian Y; Huang J; Yao W; Li J; Zhang Q; Liang T
Int J Surg; 2022 Sep; 105():106852. PubMed ID: 36030036
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
[TBL] [Abstract][Full Text] [Related]
11. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis.
Xia F; Zhang Q; Chen X; Zhang B; Ndhlovu E; Zhang M; Zhu P
Surg Endosc; 2022 Dec; 36(12):8992-9000. PubMed ID: 35920912
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.
Ye TW; Wang DD; Lu WF; Xie YM; Xu FQ; Fu TW; Zhang KJ; Liu SY; Xie GL; Cheng J; Jiang K; Xiao ZQ; Yao WF; Shen GL; Liu JW; Huang DS; Zhang CW; Liang L
Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):395-403. PubMed ID: 36939280
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
20. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
